急性早幼粒细胞白血病早期死亡危险因素分析(3)
[3] Zhu HH,Wu DP,Jin J,et al. Oral tetra-arsenic tetra-sulfide formula versus intravenous arsenic trioxide as first-line treatment of acute promyelocytic leukemia:A multicenter randomized controlled trial[J]. J Cell Biol,2013,31(33):4215-4221.[4] Chendamarai E ......
您现在查看是摘要页,全文长 2207 字符。